Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Simmons

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|September 9, 2022
T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current DevelopmentsGary L Simmons, Omar Castaneda Puglianini
Expert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven Grant
Best Practice & Research. Clinical Haematology|October 9, 2021
Clinical experience of CAR T cells for multiple myelomaGary L Simmons, Toshihisa Satta, Omar Castaneda Puglianini
Frontiers in Oncology|March 4, 2026
Advancing access to CAR T-cell therapy: insights and real-world experience from a community oncology practiceGary L Simmons, Scott Cross, Elias C Pittos
Ejhaem|October 17, 2024
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipientsGary L Simmons, Roy Sabo, Rehan Qayyum, et al.
Cancer Research|June 14, 2012
CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapiesShuang Chen, Yun Dai, Xin-Yan Pei, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|September 9, 2022
T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current DevelopmentsGary L Simmons, Omar Castaneda Puglianini
Expert Opinion on Investigational Drugs|May 8, 2013
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary L Simmons, Steven Grant
Best Practice & Research. Clinical Haematology|October 9, 2021
Clinical experience of CAR T cells for multiple myelomaGary L Simmons, Toshihisa Satta, Omar Castaneda Puglianini
Frontiers in Oncology|March 4, 2026
Advancing access to CAR T-cell therapy: insights and real-world experience from a community oncology practiceGary L Simmons, Scott Cross, Elias C Pittos
Ejhaem|October 17, 2024
Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipientsGary L Simmons, Roy Sabo, Rehan Qayyum, et al.
Cancer Research|June 14, 2012
CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapiesShuang Chen, Yun Dai, Xin-Yan Pei, et al.
Pageof 1